These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 21756176)
1. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942 [TBL] [Abstract][Full Text] [Related]
3. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829 [TBL] [Abstract][Full Text] [Related]
4. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma. Brown PM; Tzannes S; Nguyen S; White J; Langova V Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557 [TBL] [Abstract][Full Text] [Related]
5. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs. Rassnick KM; Bailey DB; Malone EK; Intile JL; Kiselow MA; Flory AB; Barlow LL; Balkman CE; Barnard SM; Waite AH Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406 [TBL] [Abstract][Full Text] [Related]
6. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000). Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709 [TBL] [Abstract][Full Text] [Related]
7. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005). Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma. Saba CF; Thamm DH; Vail DM J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160 [TBL] [Abstract][Full Text] [Related]
9. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837 [TBL] [Abstract][Full Text] [Related]
11. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs. Morgan E; O'Connell K; Thomson M; Griffin A Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253 [TBL] [Abstract][Full Text] [Related]
12. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy. Blaxill J; Buzzacott P; Finlay J Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007). Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphoma. LeBlanc AK; Mauldin GE; Milner RJ; LaDue TA; Mauldin GN; Bartges JW Vet Comp Oncol; 2006 Mar; 4(1):21-32. PubMed ID: 19754826 [TBL] [Abstract][Full Text] [Related]
15. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006). Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031 [TBL] [Abstract][Full Text] [Related]
16. Asparaginase and MOPP treatment of dogs with lymphoma. Brodsky EM; Maudlin GN; Lachowicz JL; Post GS J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma. Saba CF; Hafeman SD; Vail DM; Thamm DH J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma. Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs. Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147 [TBL] [Abstract][Full Text] [Related]
20. Comparison of combination l-asparaginase plus CHOP or modified MOPP treatment protocols in dogs with multi-centric T-cell or hypercalcaemic lymphoma. Angelo G; Cronin K; Keys D J Small Anim Pract; 2019 Jul; 60(7):430-437. PubMed ID: 30790291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]